Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.

By Giuseppe Lippi, C. Mattiuzzi, Giovanni Targher. New England Journal of Medicine, 2010

1,050 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism

View Paper: https://www.semanticscholar.org/paper/9f8045462858233147c7b0f9924081ca2dee7f85

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. V. Basevi
2. D. Magliano
3. P. Zimmet
4. G. Bakris
5. Å. Lernmark
6. D. Nathan
7. M. S. Kirkman
8. S. Grundy

Citations in the corpus

• Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2002, background): “4% higher than whites (229); however, race did not modify the association between HbA1c concentration and adverse cardiovascular outcomes or death (229).”
• Standards of Medical Care in Diabetes—2013 (2012, background): “In a communitybased study of black and white adults without diabetes, baseline A1C was a stronger predictor of subsequent diabetes and cardiovascular events than was fasting glucose (16).”
• 2. Classification and Diagnosis of Diabetes (2014, background): “In a community-based study of African American and non-Hispanic white adults without diabetes, baseline A1C was a stronger predictor of subsequent diabetes and cardiovascular events than fasting glucose (13).”
• 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020 (2019, background): “In a communitybased study of African American and non-Hispanic white adults without diabetes, baseline A1C was a stronger predictor of subsequent diabetes and cardiovascular events than fasting glucose (50).”
• Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome. (2018, background): “Although the diagnosis of diabetes is based on an A1C threshold for developing microvascular disease, A1C is also a continuous cardiovascular (CV) risk factor and a better predictor of CV events than FPG or 2hPG (23,24).”
• 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018 (2017, background): “In a community-based study of African American and non-Hispanic white adults without diabetes, baseline A1C was a stronger predictor of subsequent diabetes and cardiovascular events than fasting glucose (27).”
• Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus (2010, background): “A recent report regarding diagnostic exploration for the risk of diabetes indicates that, compared to the fasting plasma glucose level, HbA1c shows an equivalent relationship to the risk of developing diabetes mellitus and a stronger relationship with cardiovascular diseases and death [47].”
• Standards of Medical Care in Diabetes—2014 (2013, background): “In a community-based study of African American and nonHispanic white adults without diabetes, baseline A1Cwas a stronger predictor of subsequent diabetes and cardiovascular events than fasting glucose (16).”
• Diagnosis and Classification of Diabetes Mellitus (2013, background): “In a community-based study of black and white adults without diabetes, baseline A1C was a stronger predictor of subsequent diabetes and cardiovascular events than was fasting glucose (11).”
• 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2019 (2018, background): “In a community-based study of African American and non-Hispanic white adults without diabetes, baseline A1C was a stronger predictor of subsequent diabetes and cardiovascular events than fasting glucose (42).”
• The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives (2012, background): “but also a substantially increased risk of incident cardiovascular events and deaths”
• 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. (2020, background): “In a community-based study of African American and non-Hispanic White adults without diabetes, baseline A1C was a stronger predictor of subsequent diabetes and cardiovascular events than fasting glucose (61).”